Key result
Adults with cyanotic congenital heart disease had preserved flow-mediated vasodilatation (106.5% vs 106.4%, p=0.95) but lower reactive hyperaemia (409% vs 611%, p<0.0001) compared to controls.
Why the study?
Endothelial function had previously been evaluated only in smaller CCHD cohorts with variable results, leaving endothelial function and carotid atherosclerosis incompletely defined.
Do adults with cyanotic congenital heart disease have impaired endothelial function and increased carotid atherosclerosis compared to matched controls?
Case-Control (n=90)
Yes
Do adults with cyanotic congenital heart disease have impaired endothelial function and increased carotid atherosclerosis compared to matched controls?
Absolute Event Rate: 106.5% vs 106.4%
p-value: p=0.95
Adults with cyanotic congenital heart disease have preserved endothelial function and comparable carotid atherosclerosis to controls, suggesting a similar risk of atherosclerosis.
Preserved FMD and equivalent carotid atherosclerosis in CCHD suggest similar risk; leaves open whether cyanosis protects against atherosclerosis.
Patients with cyanotic congenital heart disease (CCHD) may have a low burden of atherosclerosis. Endothelial dysfunction is an early stage of atherosclerosis and endothelial function is previously studied in smaller CCHD groups with different techniques and variable results. We aimed to examine endothelial function and carotid atherosclerosis in a larger group of CCHD patients. This multicentre study assessed endothelial function in adults with CCHD and controls by measuring the dilatory response of the brachial artery to post-ischemic hyperaemia (endothelium-dependent flow-mediated-vasodilatation (FMD)), and to nitroglycerin (endothelium-independent nitroglycerin-induced dilatation (NID)). Flow was measured at baseline and after ischaemia (reactive hyperaemia). Carotid-intima-media-thickness (CIMT), prevalence of carotid plaque and plaque thickness (cPT-max) were evaluated ultrasonographically. Lipoproteins, inflammatory and vascular markers, including sphingosine-1-phosphate (S1P) were measured. Forty-five patients with CCHD (median age 50 years) and 45 matched controls (median age 52 years) were included. The patients presented with lower reactive hyperaemia (409 ± 114% vs. 611 ± 248%, p < 0.0001), however preserved FMD response compared to controls (106.5 ± 8.3% vs. 106.4 ± 6.1%, p = 0.95). In contrast, NID was lower in the patients (110.5 ± 6.1% vs. 115.1 ± 7.4%, p = 0.053). There was no difference in CIMT, carotid plaque or cPT-max. The patients presented with lower high-density-lipoprotein cholesterol, and higher level of inflammatory markers and S1P. Adults with CCHD had preserved FMD in the brachial artery, but impaired NID response and lower reactive hyperaemia than controls. The preserved FMD and the comparable prevalence of carotid atherosclerosis indicate that CCHD patients have the same risk of atherosclerosis as controls.
No takes yet. Share an insight, caveat, or question.
Tarp et al. (2020) conducted a case-control in Cyanotic congenital heart disease (n=90). Cyanotic congenital heart disease vs. Matched controls was evaluated on Endothelium-dependent flow-mediated-vasodilatation (FMD) (p=0.95). Adults with cyanotic congenital heart disease had preserved flow-mediated vasodilatation (106.5% vs 106.4%, p=0.95) but lower reactive hyperaemia (409% vs 611%, p<0.0001) compared to controls.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: